Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Income margin | 24.0% | 24.0% | 23.5% | 21.4% | 27.2% | 29.2% | 31.1% | 33.7% | 37.8% | 37.7% | 38.8% | 45.8% | 43.3% | 43.8% | 42.2% | 43.0% | 42.6% | 41.7% | 42.3% | 44.2% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Operating Income margin is 43.8%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Operating Income margin for Novo Nordisk A/S have been 41.5% over the past three years, and 43.5% over the past five years.
As of today, Novo Nordisk A/S's Operating Income margin is 43.8%, which is higher than industry median of (916.0%). It indicates that Novo Nordisk A/S's Operating Income margin is Good.